• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Cellebrite DI Ltd. - Ordinary Shares (NQ:CLBT)

    15.70 +0.63 (+4.18%)
    Streaming Delayed Price Updated: 1:39 PM EDT, Aug 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 384,841
    Open 14.87
    Bid (Size) 15.69 (500)
    Ask (Size) 15.71 (500)
    Prev. Close 15.07
    Today's Range 14.81 - 15.77
    52wk Range 11.02 - 19.98
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Cellebrite CEO Thomas Hogan Sells 103,000 Shares for $1.6 Million: Is This a Concern for Investors? ↗
    Hogan's non-discretionary sale satisfied tax withholding obligations from vesting RSUs. He retains 590,777 shares worth $9.25 million. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market ↗
    Credo, Cellebrite, and TransMedics are building dominant positions in huge markets with years of expansion still ahead. 
    Via The Motley Fool
    Topics Artificial Intelligence

    Performance

    YTD
    -12.0%
    -12.0%
    1 Month
    -5.5%
    -5.5%
    3 Month
    +15.1%
    +15.1%
    6 Month
    +5.4%
    +5.4%
    1 Year
    +15.1%
    +15.1%

    More News

    Read More
    News headline image
    Stride Stock Is Down 40% This Past Year. Here's Why One Investor Added $58 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    Cellebrite DI Ltd (NASDAQ:CLBT) Q1 Results Miss Revenue Target but Beat EPS ↗
    Via Chartmill
    Cellebrite DI Ltd (NASDAQ:CLBT) Reports Record Q4 2025 Results Amid Mixed Market Reaction ↗
    Via Chartmill
    News headline image
    Choice Hotels Stock Is Down 15%, but One Investor Bought $101 Million Last Quarter ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows ↗
    Via MarketBeat
    Topics Artificial Intelligence
    News headline image
    What to Know About This Fund's $59 Million Astronics Bet Amid a 170% One-Year Stock Surge ↗
    Via The Motley Fool
    Topics Energy Regulatory Compliance Supply Chain
    News headline image
    This Chip Stock Soared 325%. Why One Investor Still Sold $89 Million Worth ↗
    Via The Motley Fool
    Topics Regulatory Compliance Supply Chain
    News headline image
    Cellebrite DI Sees Federal Rebound as AI, Defense Tools Fuel New Growth ↗
    Via MarketBeat
    Topics Artificial Intelligence
    News headline image
    Cellebrite (CLBT) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Cellebrite DI Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Artificial Intelligence Earnings
    News headline image
    Cellebrite: Is This Stock Worth the Investment? ↗
    Via The Motley Fool
    News headline image
    IRadimed Stock Up 80% in One Year as Fund Sells $29 Million Stake Amid Record Quarter ↗
    Via The Motley Fool
    News headline image
    Resolute Holdings Stock Soars 400% as Nine Ten Trims $5 Million From Stake ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Cellebrite (CLBT) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Norwood Investment Partners Opens New $4.3 Million Cellebrite Position ↗
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    10 AI Stocks Worth Buying Right Now ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Cellebrite Completes Acquisition of Corellium, Extending the Industry’s Most Advanced AI-Powered Digital Investigation Platform
    From Cellebrite DI Ltd
    Via GlobeNewswire
    News headline image
    Should Investors Buy Shares of Cellebrite Alongside Portolan Capital as They Double Down on the Stock? ↗
    Via The Motley Fool
    News headline image
    These Fast-Rising Tech Stocks Are Surging in Growth Scores This Week ↗
    Via Benzinga
    News headline image
    This Fund Sold $9 Million of Ligand Stock After an 84% Rally — What Investors Should Know ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why One Small-Cap Fund Bought $11 Million in Cellebrite Stock Last Quarter ↗
    Via The Motley Fool
    News headline image
    This Fund Cut $7.3 Million of Atlas Energy Stock as the Company Suspends Its Dividend to Help Fuel Growth ↗
    Via The Motley Fool
    Topics Economy Regulatory Compliance
    News headline image
    Why Cellebrite Stock Is Skyrocketing Today ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Cellebrite DI Ltd. - Ordinary Shares publicly traded?
    Yes, Cellebrite DI Ltd. - Ordinary Shares is publicly traded.
    What exchange does Cellebrite DI Ltd. - Ordinary Shares trade on?
    Cellebrite DI Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Cellebrite DI Ltd. - Ordinary Shares?
    The ticker symbol for Cellebrite DI Ltd. - Ordinary Shares is CLBT on the Nasdaq Stock Market
    What is the current price of Cellebrite DI Ltd. - Ordinary Shares?
    The current price of Cellebrite DI Ltd. - Ordinary Shares is 15.70
    When was Cellebrite DI Ltd. - Ordinary Shares last traded?
    The last trade of Cellebrite DI Ltd. - Ordinary Shares was at 08/04/26 01:39 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.